Statin Drugs Gain Traction as Potential Treatment for Alzheimer's Disease

14-Nov-2006

statins are gaining attention as a potential new way of treating Alzheimer's disease (AD) according to recent reports. The Wall Street Journal noted the promise of statins for Alzheimer's disease and highlighted the pressing need for new and effective treatments for this major disease (October 17, 2006 Several Drugs Show Promise For Alzheimer's). A series of recent scientific studies have explored the link between Alzheimer's disease, cognitive function and high cholesterol levels and other cardiovascular risk factors, and the possible role that statins may have in treating or preventing Alzheimer's disease.

Nymox Pharmaceutical Corporation holds U.S. and global patent rights for the use of statin drugs for the prevention and treatment of AD, including for patients at risk for AD because of vascular-related risk factors or disease.

Other news from the department research and development

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance